Literature DB >> 12009204

Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum.

R G A Jones1, J Landon.   

Abstract

Enzyme-cleaved antibodies are used widely for the treatment of envenoming. Such products should comprise only 'highly pure' immunoglobulin fragments since Fc or other contaminating protein fragments or their aggregates may lead to side effects. The digestion of ovine antiserum and its purified IgG were investigated using pepsin and trypsin. Trypsin was effective at digesting purified IgG but unsuitable for the direct digestion of serum. In contrast, pepsin was highly effective at digesting all unwanted serum components to low molecular weight (< or =13 kDa) fragments while leaving the approximately 100-kDa F(ab')(2) intact. The optimum pH for pepsin digestion was between 3.25 and 3.50. The effects of salt concentration and pH on the digestion products were investigated by size exclusion chromatography under various conditions, which revealed a pH-dependent aggregation of some of the low molecular weight Fc and non-IgG fragments. These high molecular weight aggregates were not shown by SDS-PAGE. Unwanted low molecular weight fragments could be removed simply by diafiltration with a 30-kDa nominal molecular weight cutoff membrane and piperazine buffer (containing 150 mM NaCl, pH 6), leaving an F(ab')(2) solution contaminated only with some pepsin and a small amount of the aggregated low molecular weight fragments. These highly acidic contaminants were then removed easily using an anion exchange column and the F(ab')(2) produced following a subsequent concentration step was essentially free from pepsin and aggregates with a purity of over 96% and a yield of 19.3 g F(ab')(2)/l serum. This novel, high yield method for processing serum to highly pure F(ab')(2) avoids salt precipitation and centrifugation and should be suitable for large-scale production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009204     DOI: 10.1016/s0022-1759(02)00031-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  17 in total

1.  IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells.

Authors:  Robin Parihar; Julie Dierksheide; Yan Hu; William E Carson
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

2.  bisFabs: Tools for rapidly screening hybridoma IgGs for their activities as bispecific antibodies.

Authors:  Sanket Patke; Ji Li; Peiyin Wang; Dion Slaga; Jennifer Johnston; Sunil Bhakta; Siler Panowski; Liping L Sun; Teemu Junttila; Justin M Scheer; Diego A Ellerman
Journal:  MAbs       Date:  2017-01-26       Impact factor: 5.857

3.  Click-Engineered, Bioresponsive, and Versatile Particle-Protein-Dye System.

Authors:  Mary K Burdette; Ragini Jenkins; Yuriy P Bandera; Haley Jones; Isabell K Foulger; Ashley Dickey; Anna-Liisa Nieminen; Stephen H Foulger
Journal:  ACS Appl Bio Mater       Date:  2019-07-01

4.  Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris.

Authors:  Kazuyuki Tsunoda; Takayuki Ota; Masataka Saito; Tsuyoshi Hata; Atsushi Shimizu; Akira Ishiko; Taketo Yamada; Taneaki Nakagawa; Andrew P Kowalczyk; Masayuki Amagai
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

5.  The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Authors:  Sami El Khatib; Mohamed Salla
Journal:  Leuk Res Rep       Date:  2022-06-27

6.  Removal of Fc Glycans from [89Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8+ T Cells.

Authors:  Jordan M White; Outi M Keinänen; Brendon E Cook; Brian M Zeglis; Heather M Gibson; Nerissa T Viola
Journal:  Mol Pharm       Date:  2020-05-12       Impact factor: 4.939

7.  Engineering a rigid protein tunnel for biomolecular detection.

Authors:  Mohammad M Mohammad; Raghuvaran Iyer; Khalil R Howard; Mark P McPike; Philip N Borer; Liviu Movileanu
Journal:  J Am Chem Soc       Date:  2012-05-25       Impact factor: 15.419

8.  Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin.

Authors:  Aggeliki D Sali; Ioannis Karakasiliotis; Maria Evangelidou; Stratis Avrameas; Peggy Lymberi
Journal:  Clin Transl Immunology       Date:  2015-10-02

9.  Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G.

Authors:  Hadi Nasiri; Zahra Valedkarimi; Leili Aghebati-Maleki; Jalal Abdolalizadeh; Tohid Kazemi; Mojghan Esparvarinha; Jafar Majidi
Journal:  Vet Res Forum       Date:  2017-12-15       Impact factor: 1.054

10.  IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.

Authors:  Anna E Schager; C Coral Dominguez-Medina; Francesca Necchi; Francesca Micoli; Yun Shan Goh; Margaret Goodall; Adriana Flores-Langarica; Saeeda Bobat; Charlotte N L Cook; Melissa Arcuri; Arianna Marini; Lloyd D W King; Faye C Morris; Graham Anderson; Kai-Michael Toellner; Ian R Henderson; Constantino López-Macías; Calman A MacLennan; Adam F Cunningham
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.